PHK
UBX

Point72 Hong Kong’s Unity Biotechnology UBX Stock Holding History

Point72 Hong Kong’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-86
Closed -$1K – 2333
2021
Q4 		$1K Hold
86
– – ﹤0.01% 1813
2021
Q3 		$3K Hold
86
– – ﹤0.01% 1875
2021
Q2 		$4K Hold
86
– – ﹤0.01% 1812
2021
Q1 		$5K Sell
86
-121
-58% -$8.25K ﹤0.01% 1659
2020
Q4 		$11K Sell
207
-59
-22% -$2.85K ﹤0.01% 1529
2020
Q3 		$9K Buy
+266
New +$16.8K ﹤0.01% 1011
2020
Q1 		– Sell
-357
Closed -$26K – 1368
2019
Q4 		$26K Buy
+357
New +$25.2K 0.01% 834
2019
Q2 		– Sell
-133
Closed -$11K – 1409
2019
Q1 		$11K Buy
+133
New +$15.1K ﹤0.01% 755

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Point72 Hong Kong's UBX Position: Q1 2022 in Review

Point72 Hong Kong sold out of Unity Biotechnology (UBX) in Q1 2022, closing a stake of 86 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in UBX in Q1 2019 and held it in 8 quarters. The position peaked at $26K in Q4 2019. 70 funds tracked by Wall St. Rank hold UBX as of Q1 2022.

  • Point72 Hong Kong reported no remaining Unity Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 86 Unity Biotechnology shares in Q1 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Unity Biotechnology in Q1 2019 and held it in 8 quarters.
  • Point72 Hong Kong's Unity Biotechnology position peaked at $26K in Q4 2019.
  • 70 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.